Fennec Total Liab from 2010 to 2025
| FENC Stock | USD 6.67 0.05 0.76% |
Total Liabilities | First Reported 2000-06-30 | Previous Quarter 64.1 M | Current Value 50.5 M | Quarterly Volatility 13.3 M |
Check Fennec Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fennec Pharmaceuticals' main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Depreciation And Amortization of 1.4 M or Interest Expense of 4.1 M, as well as many indicators such as Price To Sales Ratio of 3.45, Dividend Yield of 0.0 or Days Sales Outstanding of 93.98. Fennec financial statements analysis is a perfect complement when working with Fennec Pharmaceuticals Valuation or Volatility modules.
Fennec | Total Liab |
Latest Fennec Pharmaceuticals' Total Liab Growth Pattern
Below is the plot of the Total Liab of Fennec Pharmaceuticals over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. Fennec Pharmaceuticals' Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Fennec Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Total Liab | 10 Years Trend |
|
Total Liab |
| Timeline |
Fennec Total Liab Regression Statistics
| Arithmetic Mean | 12,824,379 | |
| Geometric Mean | 4,137,649 | |
| Coefficient Of Variation | 145.60 | |
| Mean Deviation | 15,015,386 | |
| Median | 3,207,000 | |
| Standard Deviation | 18,672,614 | |
| Sample Variance | 348.7T | |
| Range | 52.6M | |
| R-Value | 0.75 | |
| Mean Square Error | 163.7T | |
| R-Squared | 0.56 | |
| Significance | 0.0008 | |
| Slope | 2,939,852 | |
| Total Sum of Squares | 5230T |
Fennec Total Liab History
About Fennec Pharmaceuticals Financial Statements
Fennec Pharmaceuticals stakeholders use historical fundamental indicators, such as Fennec Pharmaceuticals' Total Liab, to determine how well the company is positioned to perform in the future. Although Fennec Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. For example, changes in Fennec Pharmaceuticals' assets and liabilities are reflected in the revenues and expenses on Fennec Pharmaceuticals' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Fennec Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Liabilities | 50.5 M | 53 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out the analysis of Fennec Pharmaceuticals Correlation against competitors. For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fennec Pharmaceuticals. If investors know Fennec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fennec Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Fennec Pharmaceuticals is measured differently than its book value, which is the value of Fennec that is recorded on the company's balance sheet. Investors also form their own opinion of Fennec Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Fennec Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fennec Pharmaceuticals' market value can be influenced by many factors that don't directly affect Fennec Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fennec Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fennec Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fennec Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.